# How smaller pharma teams are rethinking safety surveillance

- Articles, Resources
- September 22, 2025

Qinecsa VP Product Management QVW, Jonathan Messer, has been featured in Drug Discovery World’s latest issue, where he discusses that the rise in global regulatory expectations could catch smaller marketing authorisation holders risk off-guard with their reliance on rudimentary signal detection practices.

[Read article](https://www.ddw-online.com/how-smaller-pharma-teams-are-rethinking-safety-surveillance-36959-202509/)

## Recent Articles

### [The Productivity Crisis That Persists Even Now: What Will It Take to Free Up PV Professionals to Assess Safety, Rather Than Coordinate Data?](/content/resources/the-productivity-crisis-that-persists-even-now-what-will-it-take-to-free-up-pv-professionals-to-assess-safety-rather-than-coordinate-data/index.html)

- July 28, 2026

### [Embracing quantitative signal detection methods as a smaller MAH](/content/resources/embracing-quantitative-signal-detection-methods-as-a-smaller-mah/index.html)

- June 25, 2026

### [Real-Time Safety Signals Drive Continuous PV Insight](/content/articles/real-time-safety-signals-drive-continuous-pv-insight/index.html)

- May 27, 2026

### [From Complaint Handling to Active Surveillance](/content/resources/from-complaint-handling-to-active-surveillance/index.html)

- May 5, 2026

### [Continuous Safety Surveillance for Medical Devices](/content/resources/continuous-safety-surveillance-for-medical-devices/index.html)

- May 5, 2026

### [Are patient outcomes getting lost in safety data complexity?](/content/resources/are-patient-outcomes-getting-lost-in-safety-data-complexity/index.html)

- May 5, 2026

[PreviousStatistical Significance: Could Small Pharma make more of Signal Detection](/content/resources/statistical-significance-could-small-pharma-make-more-of-signal-detection/index.html)

[NextApplying AI to adverse event case processing](/content/resources/applying-ai-to-adverse-event-case-processing/index.html)